R
Robert H. Young
Researcher at Harvard University
Publications - 629
Citations - 40683
Robert H. Young is an academic researcher from Harvard University. The author has contributed to research in topics: Adenocarcinoma & Ovarian tumor. The author has an hindex of 107, co-authored 617 publications receiving 37994 citations. Previous affiliations of Robert H. Young include North Shore-LIJ Health System & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder
Jonathan I. Epstein,Mahul B. Amin,Victor R. Reuter,Fathollah K. Mostofi,Ferran Algaba,William C. Allsbrook,Alberto G. Ayala,Michael J. Becich,Antonio Lòpez Beltran,Lilliane Boccon-Gibod,David G. Bostwick,Christer Busch,Charles J. Davis,John N. Eble,Christopher S. Foster,Masakuni Furusato,David J. Grignon,Peter A. Humphrey,Elia A. Ishak,Sonny L. Johansson,Edward C. Jones,Leopold G. Koss,Howard S. Levin,William M. Murphy,Robert O. Petersen,Andrew A. Renshaw,Jae Y. Ro,Jeffrey R. Ross,Isabell A. Sesterhenn,John R. Srigley,Sueli Suzigan,John B. Tomaszewski,Patricia Troncoso,Lawrence D. True,Mark Weiss,Thomas M. Wheeler,Robert H. Young +36 more
TL;DR: The aim was to develop a universally acceptable classification system for bladder neoplasia that could be used effectively by pathologists, urologists, and oncologists.
Journal ArticleDOI
Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases
TL;DR: It is concluded that low-grade tumors confined to the appendix are morphologically identical to those with extra-appendiceal spread and the same designation is appropriate for the appendiceal neoplasia in each situation.
Journal ArticleDOI
Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases.
TL;DR: There was a relation of size, mitotic activity, and nuclear atypia to the outcome when tumors of all stages were evaluated, but no such relation was evident when only Stage Iai and Ibi tumors were considered.
Journal ArticleDOI
Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone
William U. Shipley,Lynn Verhey,John E. Munzenrider,Herman D. Suit,Marcia Urie,P.L. McManus,Robert H. Young,Jenot W. Shipley,Anthony L. Zietman,Peter J. Biggs,Niall M. Heney,Michael Goitein +11 more
TL;DR: An increase in prostate tumor dose by external beam of 12.5% to 75.6 Cobalt Gray Equivalent using a conformal perineal proton boost significantly improved local control only in patients with poorly differentiated tumors.